System Transmission

Top Signal

100#1 JOB

Activity

2180Ripe

+936 today

System

Live1m

Terminal Asset View

stockNASDAQ

INVA

$22.03+0.27%

Innoviva Inc

Ripening

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

61Ripening

Live Analysis Active

Company Mission

Innoviva manages royalty rights for respiratory medicines developed by other pharmaceutical companies. When doctors prescribe these drugs to patients with breathing problems, Innoviva earns a percentage of the sales revenue. The company doesn't develop new medicines itself but profits from existing successful treatments.

INV

Industry Context

Innoviva operates in the pharmaceutical royalty sector, where companies earn money from existing drugs rather than developing new ones. This industry faces challenges as patents expire on blockbuster drugs and healthcare regulations change, creating uncertainty for royalty streams.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

66Matrix

Market Momentum

47.2— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

0.27%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing INVA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 01:04 PM UTC

As-of 03-15-2026 12:49 UTC

Develops and licenses respiratory medicines, earning royalties when pharmaceutical partners sell these drugs to treat lung diseases.

Weekly price swings are getting smaller near recent levels, suggesting a potential bigger move is building up showing consolidation pattern.

Healthcare sector faces patent expirations and regulatory changes, creating volatility that affects royalty-dependent companies like Innoviva,.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...